SCHEMBL13638645

SCHEMBL13638645

CNc1cc2ncn(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(C)s4)cc3)c(=O)c2cc1Br

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY12 Q9H244 1/20 0.43
ESR1 P03372 2/20 0.36
ESR2 Q92731 2/20 0.36
FBP1 P09467 5/20 0.33
ATM Q13315 2/20 0.33
SMN1; SMN2 Q16637 3/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
MEN1 O00255 1/20 0.32
S1PR4 O95977 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
TP53 P04637 1/20 0.32
PKM P14618 1/20 0.32
HPGD P15428 1/20 0.32
ALOX15 P16050 1/20 0.32
S1PR1 P21453 1/20 0.32
HTT P42858 1/20 0.32
KMT2A Q03164 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9922131 0.91 P2RY12 (0.54) P2RY12ESR1ESR2FBP1ATM
SCHEMBL13638374 0.90 P2RY12 (0.39) P2RY12FBP1SMN1; SMN2MEN1S1PR4
SCHEMBL14228576 0.87 P2RY12 (0.49) P2RY12ATMLMNATP53PPARG
SCHEMBL13638371 0.84 P2RY12 (0.38) P2RY12ESR1ESR2ATMSMN1; SMN2
SCHEMBL14228643 0.83 PPARG (0.41) P2RY12ESR1ESR2ATMRAB9A
SCHEMBL12177640 0.83 ESR1 (0.39) P2RY12ESR1ESR2ATMSMN1; SMN2
SCHEMBL13638370 0.83 P2RY12 (0.38) P2RY12ESR1ESR2ATMSMN1; SMN2
SCHEMBL9922130 0.82 P2RY12 (0.55) P2RY12ESR1ESR2FBP1SMN1; SMN2
SCHEMBL13638369 0.82 ESR1 (0.38) P2RY12ESR1ESR2ATMSMN1; SMN2
SCHEMBL13638647 0.82 P2RY12 (0.39) P2RY12ESR1ESR2ATMSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622474-B2 Asulfonyl(urea, thiourea, guanidine, cyanoguanidine) compounds; cardiovascular disorders; thrombosis PORTOLA PHARMACEUTICALS, INC. (US) 2009-11-24 US disclosed